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ABSTRACT 
Objective: This research aims to determine the amount of hydroxypropyl methylcellulose (HPMC) and chitosan, which can produce the optimum 
buccal film formula and to determine the release kinetics of diltiazem hydrochloride in vitro.  
Methods: The film was prepared by the solvent casting method. The formula's optimization was carried out using factorial design, which was 
processed using Design Expert 11.0.0 software, while the release kinetics was analyzed using the DDSolver program.  
Results: The optimization results show that HPMC and chitosan (30 mg: 10 mg) is the amount of polymer that can produce the optimum formula. 
The buccal film formula has a swelling index of 2.92, a mucoadhesive strength of 64.40 gF, and a mucoadhesive residence time of 464 min. In vitro 
release study showed 97.64% release of Diltiazem hydrochloride after 480 min. The release kinetic’s of diltiazem hydrochloride follow the 
Korsmeyer Peppas model.  
Conclusion: Thus, it can be concluded that the prepared formulation of the buccal mucoadhesive film can be a delivery system for diltiazem 
hydrochloride. 
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INTRODUCTION 
Hypertension is a persistent increase in systolic and diastolic blood 
pressure more than 140 mmHg and 90 mmHg. Diltiazem hydrochloride 
can reduce Hypertension [1]. In vivo, diltiazem hydrochloride has 40% 
bioavailability due to first-pass metabolism [2]. The buccal delivery 
system is suitable as an alternative for diltiazem hydrochloride drug 
delivery because it could avoid the first-pass metabolism.  
Buccal preparations include patch, tablet, semisolid, powder, and 
film [3]. The buccal film is thinner, smaller in size, minimal side 
effects, and flexible [4, 5]. The bilayered buccal film consists of an 
insoluble backing layer and a mucoadhesive layer containing drugs. 
The backing layer uses to regulate the drug release in one direction 
so that it prevents the drug from dissolving in saliva, prevents loss of 
the drug from the top, and can mask the drug's bitter taste [6]. The 
mucoadhesive layer uses to prolong drug contact with mucus [7]. 
In this study, the solvent casting method uses to prepare the buccal 
film. The type and amount of polymer used for the buccal film will 
influence the characteristics, kinetics, and drug release mechanism 
from buccal film preparation. Therefore, in this research, we will 
optimize HPMC and chitosan composition using a factorial 
design. HPMC and chitosan are polymers that can expand and form 
polymer chains if attached to the mucosa [8, 9]. HPMC is a polymer 
with good film-forming properties, transparent and better 
mucoadhesive properties [10, 11]. Chitosan is a natural polysaccharide 
from chitin deacetylation that is non-toxic, biodegradable, and 
biocompatible [12]. Chitosan also has good mucoadhesive properties 
[13]. The combination of these two polymers could increase the 
mucoadhesive strength and film residence time.  
Dissolution is critical for absorption and bioavailability; therefore, 
information on the release mechanism and kinetics is essential to 
evaluate. The DD Solver program is simple and easy to use for data 
dissolution modeling [14]. DD Solver is a program developed to 
analyze dissolution data kinetics [15] with a non-linear regression 
approach. Hence, the model and mechanism of dissolution of 
Diltiazem hydrochloride mucoadhesive buccal film were evaluated 
with the help of DD Solver program. 
MATERIALS AND METHODS 
Chemical and reagent 
Materials used in this study were Diltiazem hydrochloride from PT. 
Kimia Farma (Jakarta, Indonesia). Chitosan (94% deacetylation 
degree) was obtained from CV. Chimultiguna (Cirebon, Indonesia). 
HPMC K4M, glycerin, acetone, KH2PO4, HCl, and NaOH were purchased 
from PT. BrataChem (Jakarta, Indonesia). Ethylcellulose N-100 was 
purchased from Asian Chemical (Jakarta, Indonesia). Goat buccal 
mucosa of 3-4 y old was obtained from local slaughterhouses.  
Animal experimental 
The use of animals follows the protocol approved by the Ethics 
Committee of Medical Research Faculty of Dentistry Universitas 
Jember no. 895/UN25.8/KEPK/DL/2020. 
Instrument 
The instruments used in this study were the TA. XT2 plus Texture 
Analyzer (UK), Alpha Bruker FT-IR Spectroscopy (UK), USP paddle-
type dissolution test equipment (Logan, Germany), pH meter 
(Elmetron CP-502, Poland), UV Vis Spectrophotometer (Genesys 
10S, Thermo Scientific, USA), analytical balance (Adventurer TM 
Ohaus, USA), oven (Memmert, Germany), screw micrometer, Design-
Expert software version 11.0.0, DD Solver program, desiccator 
(Normax), and glass tools.  
Experimental design  
Formulas preparation uses a factorial design of two-factor and two-
level. The amount of polymer used is set at a low level and 
high level. The low level of HPMC is 15 mg, while the high level is 30 
mg. The low level of chitosan is 5 mg, while the high level is 10 mg. 
Buccal film preparation 
The film formula (table 1) caste on a 9 cm diameter petri dish. The 
film cuts into 2x2 cm. Each contains 40 mg of Diltiazem 
hydrochloride. Diltiazem hydrochloride and HPMC dissolve in water 
while chitosan dissolves in 1% acetic acid. The solutions mix added 
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with glycerin then stirred until homogeneous. The dissolved 
component is poured into a mold and allowed to stand for 24 h to 
remove air bubbles. The mixture was dried in an oven at 50 °C for 24 
h. The backing layer, ethylcellulose in acetone, pours on the film's 
surface containing Diltiazem hydrochloride. The next step is drying 
in an oven at 70 °C for 60 min [15].
  
Table 1: The formula composition of mucoadhesive bilayer buccal film diltiazem hydrochloride 
Materials Function Formula code 
F1 FA FB FAB 
Diltiazem hydrochloride Active ingredient 0.60 g 0.60 g 0.60 g 0.60 g 
HPMC Film forming 0.24g 0.48 g 0.24 g 0.48 g 
Chitosan Mucoadhesive 0.08 g 0.08 g 0.16 g 0.16 g 
Ethylcellulose Backing layer 0.23 g 0.23 g 0.23 g 0.23 g 
Aceton Solvent 22.5 ml 22.5 ml 22.5 ml 22.5 ml 
Glycerin Plasticizer 0.5 ml 0.5 ml 0.5 ml 0.5 ml 
Acetic acid Solvent 3 ml 3 ml 3 ml 3 ml 
Distilled water Solvent 7 ml 7 ml 7 ml 7 ml 
 
The evaluation of Physico-chemical of prepared buccal films 
The organoleptic study was performed visually by observing the color, 
taste, smell, and film texture. The film thickness was measured by 
using a screw micrometer. The Films are measured at five different 
positions. The measurement results state as the mean and standard 
deviation [16, 17]. The film weight was determined by weighing, and 
the result presented as mean and standard deviation [18]. 
The film's endurance was evaluated by repeated folding the film 300 
times in the same place until it breaks [16, 19]. 
Surface pH was determined by soaked the film in 1 ml of pH 6.8 
phosphate buffer for 2 h at room temperature; then, the surface pH 
is measured using electrodes [16].  
Determination of diltiazem hydrochloride content in a buccal film 
was carried out by dissolving a film containing 40 mg of Diltiazem 
hydrochloride in a phosphate buffer (pH 6.8). Diltiazem hydrochloride 
measures using a UV spectrophotometer at maximum wavelength 
[20]. Diltiazem hydrochloride content calculates by equation (1). 
% content of the active ingredient = content of drug in the �ilm
amount of drug added 
 x 100% (1) 
Swelling index 
The films (W0) was weighing to determine the initial weight and 
then put in a petri dish containing 5 ml of phosphate buffer (pH 6.8) 
and allowed to swell (Wt) [16, 21]. The swelling index calculated 
using equation (2). 




W0 = initial weight of the film  
Wt = final weight after time interval t 
Mucoadhesive strength 
The test was conducted using the goat's buccal mucosa by given a 
force of 500gF on a texture analyzer that was run by XTRA 
Dimension Software. The mucoadhesive strength states with units of 
gram force (gF) [22]. 
Mucoadhesive residence time  
The test performs on a buccal film by attached the film to the buccal 
mucosa for 30 s. The buccal mucosa is attached to the center of the 
slide. The slide soaked in 500 ml of phosphate buffer (pH 6.8) at 
37±0.5 °C, and stirred at 500 rpm for 8 h. The residence time is 
determined when the film begins to detach [23]. 
Fourier transform infrared (FTIR) 
FTIR test was performed to confirm the interaction between 
Diltiazem hydrochloride and film components, which could retard 
diltiazem hydrochloride release from the buccal film or reduce its 
effectiveness. Scanning did in the wavenumber of 4000-600 cm-1. 
Scanning electron microscopy (SEM) 
SEM analysis was performed by placing a film on a stub specimen 
attached to a conductive tape. The film was then placed on a 
specimen holder with a 15 kV voltage and a pressure of 0.1 mmHg. 
The top, bottom, and cross-section of the film are captured with 40, 
100, 300 magnifications. 
Analysis of data 
Each buccal film's dependent variables were processed using Design 
expert 11.0.0 to obtain the optimum formula. The release study 
analyzed using DD Solver program to determine the release kinetics 
model and mechanism. 
RESULTS AND DISCUSSION 
Physico-chemical evaluation of prepared buccal films 
Diltiazem hydrochloride mucoadhesive bilayer buccal films formula 
of F1, FA, FB, and FAB are yellow, odorless, slightly sweet, elastic, 
and smooth. The result of the buccal film Physico-chemical 
evaluation is presented in table 2.  
The buccal film's thickness meets the ideal film criteria between 50-
1000μm [24]. The Film thickness and weight uniformity relate to 
dose uniformity. Both parameters show uniformity, as indicated by 
small SD values. The film thickness and weight influence by the 
number of polymers of each different formula.  
The folding endurance test of each formula shows that the films 
resist to more than 300 times fold. These results indicate that the 
film is not easily damaged due to movement and mechanical friction 
in the oral environment [19].  
The surface pH meets the buccal pH requirements of 5.5-7 [23]; 
therefore, they do not irritate the mucosa and cause discomfort 
during use. The buccal film's Diltiazem hydrochloride content 
showed that it fulfilled 85-115% [25], which is indicates that only 
small drug loss during formulation. The coefficient of variation (CV) 
meets the CV requirements, which is less than 6% [26]. 
Measurements of swelling index 
The swelling index shows that FA>FAB>FB>F1 (table 2). FA uses a 
high number of HPMC and low number of chitosan. In a larger 
number, the FA uses HPMC to give a better swelling index due to the 
hydrophilic groups resulting in greater hydration [27]. In contrast 
with HPMC, chitosan is slightly soluble in water and only dissolves in 
acidic conditions, resulting in low hydration. 
Mucoadhesive strength 
The mucoadhesive strength shows that FAB>FA>FB>F1 (table 2). The 
FAB formula had a high level of HPMC and chitosan. The amount of 
polymer used can affect the amount of mucoadhesive strength. Less 
polymer number can reduce the number of chains per unit that will 
penetrate to the mucus. Besides, it can reduce the interaction between 
polymer and mucus; hence the bonds are unstable, while large polymer 
numbers can increase the chain penetration and adhesive properties. 
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HPMC has moderate mucoadhesive properties. In large quantities, HPMC 
can increase mucoadhesive strength [28]. The hydroxyl groups in HPMC 
bind to the mucosa to form hydrogen bonds and produce good 
properties of mucoadhesive [29]. Chitosan is a cationic polymer that can 
bind with the sialic acid groups in mucin; therefore, a large amount of 
chitosan increases the mucoadhesive strength [28].
  
Table 2: The results of buccal film evaluation 
Evaluation parameters F1 FA FB FAB 
Thickness* (cm) 0.02±0.00 0.03±0.00 0.02±0.00 0.03±0.00 
Weight* (mg) 76.10±0.45 98.70±0.27 84.90±0.27 116.80±0.45 
Folding endurance* >300x >300x >300x >300x 
Surface pH* 6.26±0.04 6.46±0.04 6.11±0.02 6.02±0.04 
Drug content* (%) 96.87±0.83 96.17±1.42 95.85±0.61 94.66±1.54 
Swelling Index* 2.35±0.02 3.28±0.01 2.68±0.04 2.92±0.02 
Mucoadhesive strength* (gF) 37.90±0.20 53.73±1.80 48.17±1.63 64.40±2.38 
Residence time* (min) 375.33±2.08 444.67±4.04 405.33±3.06 464.00±4.00 
Note: Ratio of HPMC to chitosan of F1 (15: 5); FA (30: 5); FB (15:10); FAB (30:10). Values are expressed as mean±SD, n=3 
 
Mucoadhesive residence time 
The mucoadhesive residence time showed that FAB>FA>FB>F1. The 
mucoadhesive residence time relates to the length of the buccal film 
stays at mucosa [10]. These results indicate that a combination of 
two polymers, HPMC and chitosan, could increase mucoadhesive 
strength and residence time in the mucosa. This result is in 
accordance with [9] studies using polymer combination of HPMC-
4KM with chitosan for Sodium Risedronate could increase the 
mucoadhesive strength and mucoadhesive residence time. 
Formula optimization 
The independent variables in this research were HPMC (X1) dan 
chitosan (X2), while the dependent variables were a swelling index 
(Y1), a mucoadhesive strength (Y2), and a mucoadhesive residence 
time (Y3). The swelling index, mucoadhesive strength, and 
mucoadhesive residence time were analyzed using the software of 
design expert version 11.0.0 to obtain the following equation (3), (4), 
(5): 
Swelling index (Y1) = 2.81+0.2931 * X1–0.0074 * B-0.1737 * X1X2(3) 
Mucoadhesive strength (Y2) = 51.05+8.02+5.23 * X1 * X2+0.100 * 
X1X2 (4) 
Mucoadhesive residence time (Y3) = 422.33+32.00 * X1+12.33 * X2-
2.67 * X1X2 (5) 
Where X1 = amount of HPMC; X2 = amount of chitosan. 
The contour plot of a swelling index response, mucoadhesive 
strength, and mucoadhesive residence time is shown in fig. 1. The 
red color in the contour plot shows the highest predicted response, 
while the blue color indicates the lowest predicted response.
  
 
Fig. 1: The Contour plots of a swelling index (A), a mucoadhesive strength (B), a mucoadhesive residence time (C), and an overlay plot of 
the optimum area (D) 
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The optimum area is a result of an overlay plot of a swelling index, a 
mucoadhesive strength, and mucoadhesive residence time (fig. 1). 
The optimized area produced from the overlay of the three 
responses is shown in yellow color, which indicates the amount of 
HPMC and chitosan that meet the desired criteria. FAB is the 
optimum formula with the desirability index of 0.80 containing 
HPMC and chitosan 30 mg: 10 mg. 
FTIR analysis 
FTIR spectra of Diltiazem hydrochloride in red color and 
Diltiazem hydrochloride mucoadhesive bilayer buccal film in 
blue color (fig. 2). FTIR spectra of diltiazem hydrochloride and 
diltiazem hydrochloride mucoadhesive bilayer buccal film shows 
the spectra met the characteristic range of diltiazem 
hydrochloride (fig. 2). There was no sharp band shift and 
significant changes in wavelength. Diltiazem hydrochloride 
contains an active metabolite, desacetyl diltiazem, that provides 
a therapeutic effect [2]. The metabolite's constituent group is the 
C = O amide functional group, which vibrates in the wavenumber 
of 1630-1680 cm-1 [30]. The optimum formula has the C = O 
amide group wavenumber of 1678.19 cm-1; therefore, its 
therapeutic effect did not change. 
Analysis of the release kinetics model and mechanism 
DDSolver provides several statistical criteria for evaluating an 
appropriate dissolution model. The statistical analysis results using 
several release kinetics models of diltiazem hydrochloride 
mucoadhesive bilayer buccal film can be seen in table 3. 
 
 
Fig. 2: The overlay of diltiazem hydrochloride (red color) and diltiazem hydrochloride mucoadhesive bilayer buccal film (blue color) FTIR 
spectra 
 
Table 3: Statistical parameters of diltiazem hydrochloride release kinetics (n=3) 
Parameters  Zero-order  First-order  Higuchi Hixson-crowell Korsmeyer Peppas 
R2 adjusted 0.928 0.967 0.986 0.977 0.989 
AIC 120.3 106.9 93.4 100.5 91.5 
MSC 2.5 3.3 3.7 3.5 4.8 
MSE 65.6 29.9 21.7 27.5 12.8 
WSS 1048.9 478.2 375.7 428.1 110.4 
 
The kinetics model analysis using DD Solver was determined based on 
the highest value of R2 adjusted and Model Selection Criterion 
parameters (MSC) and the smallest Akaike Information Criterion (AIC), 
mean square error MSE and the weighted sum of squares (WWS) 
parameters. The highest R2 adjusted and MSC indicate the best release 
kinetics model, and the smallest AIC, MSE, and WWS parameters showed 
a more precise release kinetics model [31]. The release kinetics model 
analyzes using DD Solver program follow Korsmesyer Peppas models 
with a value of R2 adjusted is 0.989 (table 3). This result is supported by 
the curve fitting of the predictive and observative Diltiazem 
hydrochloride release profile. The Korsmeyer Peppas model shows the 
smallest difference between Qo and Qc (fig. 3).  
The distribution of experimental data (Qo) is around the predicted 
dissolution data curve (Qc). The dissolution modeling with zero-
order, first-order, Higuchi, and Hixson-Crowell resulted in a larger 
difference between Qo and Qc [32]. The n value (release exponent) is 
0.624, indicates that the release follows a non-Fickian diffusion 
mechanism. Non-Fickian diffusion is the release of drug through 
polymer diffusion and erosion (relaxation) processes. When the 
polymer erodes, the drugs could exit from the matrix [33].  
HPMC polymer is water-soluble so that the drug diffuses from the 
expand of the polymer, which forms a gel layer [34]. The AB formula 
has a high amount of HPMC polymer so that it can absorb more 
water to undergoes wetting (swelling). The more the swelling will 
increase drug diffusion. Chitosan has erosive properties due to its 
low water solubility. From the eroded matrix, the drug can easily be 
released and dissolved [23]. The release kinetics of Ranitidine 
hydrochloride from the buccal film containing Sterculia foetida gum 
and Carbopol 934P also follows the Peppas release kinetics model by 
diffusion mechanism following non-Fickian transport [35]. 
Duloxetine hydrochloride follows the zero-order and Higuchi release 
kinetics when formulated into a buccal film using the combination of 
HPMC E 15 (hydrophilic polymer) and Eudragit RL 100 
(hydrophobic polymer). A combination of hydrophilic, low viscosity 
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polymer with a hydrophobic polymer may retard the drug release; 
therefore, the film's release follows the diffusion-controlled 
mechanism [36]. This result shows that polymers used for film 
preparation influence the release kinetics model of drugs.
 
 
Fig. 3: Diltiazem hydrochloride profile of predictive dissolution (Qp) and observative results (Qo) versus time (n = 3). (A) Zero-order; (B) 
First-order; (C) Higuchi; (D) Hisxon-Crowell; (E) Korsmeyer peppas 
 
SEM analysis (fig. 4) shows the morphology of the film on the top 
and bottom surfaces. Smooth top and bottom surface increased 
comfort during use. The cross-sectional surface at a 
magnification of 40 times and 100 times shows that the film 
consists of two-layer, the backing layer, and the mucoadhesive 
layer. The backing layer reduces the drug's loss by salivary fluid 




Fig. 4: SEM's image of the buccal film, (A) The upper surface by 300 times magnification; (B) Under surface with 300 times magnification; 
(C) Film's cross-section with a magnification of 40 times; (D) Film's cross-section with a magnification of 100 times 
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CONCLUSION 
Based on the research, the amount of HPMC polymer and chitosan 
affects the buccal mucoadhesive physical characteristic. Combining 
HPMC and chitosan could increase the mucoadhesive strength of the 
buccal mucoadhesive film and its residence time. The optimum 
formula produces by a combination of HPMC: chitosan (30 mg: 10 mg) 
based on three optimized responses, a swelling index, mucoadhesive 
strength, and mucoadhesive residence time. In vitro release study of 
the optimum formula showed the release kinetics of Diltiazem 
hydrochloride from the buccal mucoadhesive film following the 
Korsmeyer Peppas by a non-Fickian diffusion mechanism. 
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